This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1.AM Achim , M Maziade , E Raymond , etal. How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull. 2011; 37(4): 811–821.
2.C Tranulis , S Potvin , M Gourgue , etal. The paradox of quetiapine in obsessive-compulsive disorder. CNS Spectr. 2005; 10(5): 356–361.
3.F Schirmbeck , M Zink . Clozapine-induced obsessive-compulsive symptoms in schizophrenia: a critical review. Curr Neuropharmacol. 2012; 10(1): 88–95.
4.R Cunill , X Castells , D Simeon . Relationship between obsessive-compulsive symptomatology and severity of psychosis in schizophrenia: a systematic review and meta-analysis. J Clin Psychiatry. 2009; 70(1): 70–82.
5.K Mukhopadhaya , R Krishnaiah , T Taye , etal. Obsessive-compulsive disorder in UK clozapine-treated schizophrenia and schizoaffective disorder: a cause of clinical concern. J Psychopharmacol. 2009; 23(1): 6–13.
6.B Sterk , K Lankreijer , DH Linszen , L de Haan . Obsessive-compulsive symptoms in first episode psychosis and in subjects at ultra high risk for developing psychosis: onset and relationship to psychotic symptoms. Aust N Z J Psychiatry. 2011; 45(5): 400–405.
7.M Zink , U Knopf , A Kuwilsky . Management of clozapine-induced obsessive-compulsive symptoms in a man with schizophrenia. Aust N Z J Psychiatry. 2007; 41(3): 293–294.
8.M Lim , DY Park , JS Kwon , YH Joo , KS Hong . Prevalence and clinical characteristics of obsessive-compulsive symptoms associated with atypical antipsychotics. J Clin Psychopharmacol. 2007; 27(6): 712–713.
9.L deHaan , B Sterk , L Wouters , DH Linszen . The 5-years course of obsessive-compulsive symptoms and obsessive-compulsive disorder in first-episode schizophrenia and related disorders. Schizophr Bull. 2013; 39(1): 151–160.
10.MY Hwang , SW Kim , SY Yum , LA Opler . Management of schizophrenia with obsessive-compulsive features. Psychiatr Clin North Am. 2009; 32(4): 835–851.
11.L Lykouras , B Alevizos , P Michalopoulou , A Rabavilas . Obsessive-compulsive symptoms induced by atypical antipsychotics: a review of the reported cases. Prog Neuropsychopharmacol Biol Psychiatry. 2003; 27(3): 333–346.
12.B Alevizos , C Papageorgiou , GN Christodoulou . Obsessive-compulsive symptoms with olanzapine. Int J Neuropsychopharmacol. 2004; 7(3): 375–377.
13.CL Ke , CF Yen , CC Chen , etal. Obsessive-compulsive symptoms associated with clozapine and risperidone treatment: three case reports and review of the literature. Kaohsiung J Med Sci. 2004; 20(6): 295–301.
14.S Ozer , M Arsava , A Ertugrul , B Demir . Obsessive compulsive symptoms associated with quetiapine treatment in a schizophrenic patient: a case report. Prog Neuropsychopharmacol Biol Psychiatry. 2006; 30(4): 724–727.
15.S Stamouli , L Lykouras . Quetiapine-induced obsessive-compulsive symptoms: a series of five cases. J Clin Psychopharmacol. 2006; 26(4): 396–400.
18.A Ertugrul , AE Anil Yagcioglu , N Eni , KM Yazici . Obsessive-compulsive symptoms in clozapine-treated schizophrenic patients. Psychiatry Clin Neurosci. 2005; 59(2): 219–222.
19.R Mahendra , E Liew , M Subramaniam . De novo emergence of obsessive-compulsive symptoms with atypical antipsychotics in asian patients with schizophrenia or schizoaffective disorder: a retrospective, cross-sectional study. J Clin Psychiatry. 2007; 68(4): 542–545.
20.AR Sa , AG Hounie , AS Sampaio , etal. Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol. Compr Psychiatry. 2009; 50(5): 437–442.
21.L deHaan , A Oekeneva , T Van Amelsvoort , D Linszen . Obsessive-compulsive disorder and treatment with clozapine in 200 patients with recent-onset schizophrenia or related disorders. Eur Psychiatry. 2004; 19(8): 524.
22.M Poyurovsky , A Weizman , R Weizman . Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment. CNS Drugs. 2004; 18(14): 989–1010.
24.F Schirmbeck , F Rausch , S Englisch , etal. Differential effects of antipsychotics agents on obsessive-compulsive symptoms in schizophrenia: a longitudinal study. J Psychopharmacol. 2013; 27(4): 349–357.
25.S Tanahashi , S Yamamura , M Nakagawa , E Motomura , M Okada . Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes. Br J Pharmacol. 2012; 165(5): 1543–1555.
26.S Pallanti , G Grassi , A Cantisani . Approaches to treatment resistance. In: Zohar J, ed. Obsessive-Compulsive Disorder: Current Science and Clinical Practice. Hoboken, NJ: John Wiley & Sons; 2012; 99–134.
27.JS Kwon , YH Joo , HJ Nam , etal. Association of the glutamate transporter gene SLC1A1 with atypical antipsychotics-induced obsessive-compulsive symptoms. Arch Gen Psychiatry. 2009; 66(11): 1233–1241.
28.F Schirmbeck , V Nieratschker , J Frank , etal. Polymorphisms in the glutamate transporter gene SLC1A1 and obsessive-compulsive symptoms induced by second-generation antipsychotic agents. Psychiatr Genet. 2012; 22(5): 245–252.
34.SR Kay , A Fiszbein , LA Opler . The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987; 13(2): 261–276.
35.SA Montogomery , M Asberg . A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979; 134(4): 382–389.
36.M Hamilton . The assessment of anxiety states by rating. Br J Med Psychol. 1959; 32(1): 50–55.
37.W Goodman , L Price , S Rasmussen , etal. The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), part I: development, use, and reliability. Arch Gen Psychiatry. 1989; 46: 1006–1011.
38.W Goodman , L Price , S Rasmussen , etal. The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), part II: validity. Arch Gen Psychiatry. 1989; 46(11): 1012–1016.
39.A Greeven , P Spinhoven , AJ van Balkom . Hypochondriasis Y-BOCS: a study of the psychometric properties of a clinician-administered semi-structured interview to assess hypochondriacal thoughts and behaviours. Clin Psychol Psychother. 2009; 16(5): 431–443.
40.RC Hall . Global assessment of functioning: a modified scale. Psychosomatics. 1995; 36(3): 267–275.
41.V Starcevic . Hypochondriasis and health anxiety: conceptual challenges. Br J Psychiatry. 2013; 202(1): 7–8.
42.W Hiller , MM Fichter . High utilizers of medical care: a crucial subgroup among somatizing patients. J Psychosom Res. 2004; 56(4): 437–443.
43.L deHaan , N Beuk , B Hoogenboom , P Dingemans , D Linszen . Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders. J Clin Psychiatry. 2002; 63(2): 104–107.